WHO ICTRP trial
An investigation into the effects of diindolylmethane (BioResponse DIM®)…
ISRCTN47437431 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN47437431 |
|---|---|
| Public title | An investigation into the effects of diindolylmethane (BioResponse DIM®) supplementation in women with low-grade cervical cytological abnormalities |
| Scientific title | An investigation into the effects of diindolylmethane (BioResponse DIM®) supplementation in women with low-grade cervical cytological abnormalities |
| Primary sponsor | Queen Mary and Westfield College, University of London (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Specified |
| Countries | United Kingdom |
| Conditions | Cervical neoplasia. Cancer Cervical |
| Interventions | Double-blind, placebo-controlled trial. Randomisation is in the ratio 2 DIM®: 1 placebo. Diindolylmethane (BioResponse DIM® - 75 mg capsules) - two capsules daily for 6 months. |
| Registration date | Oct 25, 2005 |
| Target size | 3000 |
| Secondary IDs | NCT00462813;N/A |
| Registry page | isrctn.com |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: